BIOTRICITY INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
BIOTRICITY INC. (BTCY) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $316.29 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-19
- BIOTRICITY INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-06-30 was $316.29K, a 407.56% increase year-over-year.
- BIOTRICITY INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-06-30 was $62.32K.
- BIOTRICITY INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-06-30 was -$626.06K.
- BIOTRICITY INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-06-30 was -$502.97K.
- BIOTRICITY INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2026 was -$161.22K.
- BIOTRICITY INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$450.92K, a 1043.88% decline from fiscal 2024.
- BIOTRICITY INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $47.77K.
- BIOTRICITY INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$11.55M, a 215.75% decline from fiscal 2022.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $316.29K 10-Q · filed 2026-08-19 | ||||
| 2026-03-31 | -$161.22K 10-K · filed 2026-07-14 | ||||
| 2025-12-31 | -$48.77K 10-Q · filed 2026-02-11 | ||||
| 2025-09-30 | -$29.80K 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | $62.32K 10-Q · filed 2026-08-19 | ||||
| 2025-03-31 | -$450.92K 10-K · filed 2026-07-14 | ||||
| 2024-12-31 | -$61.30K 10-Q · filed 2026-02-11 | -$215.15K 10-Q · filed 2025-02-19 | |||
| 2024-09-30 | -$552.02K 10-Q · filed 2025-11-14 | ||||
| 2024-06-30 | -$626.06K 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | $47.77K 10-K/A · filed 2025-07-18 | ||||
| 2023-12-31 | -$574.94K 10-Q/A · filed 2025-02-20 | ||||
| 2023-09-30 | $536.48K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | -$502.97K 10-Q · filed 2024-08-19 | ||||
| 2023-03-31 | -$11.55M 10-K · filed 2024-06-27 | ||||
| 2022-12-31 | -$11.67M 10-Q · filed 2024-02-20 | ||||
| 2022-09-30 | -$9.60M 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | -$4.87M 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $9.98M 10-K · filed 2023-06-29 | ||||
| 2021-12-31 | $14.58M 10-Q · filed 2023-02-14 | ||||
| 2021-03-31 | $1.12M 10-K · filed 2022-07-14 |